Cancer Research UK is launching Major Centres at its Oxford, Manchester and Cambridge hubs to support research in early detection of cancer and personalised medicine.
To be launched today, the three Major Centres will receive £5m each for collaborative research and ‘bridging the gap between innovative laboratory work and benefits for patients’.
The programme intends to develop personalised treatments for cancer patients.
Cancer Research UK executive director for research funding Dr Iain Foulkes said: "The development of these Major Centres will accelerate national and international collaborations and improve treatments for patients.
"In each location, we are developing cutting-edge approaches in how we treat the disease, be that the detection of individual tumour cells in the blood that allow us to monitor the disease or precision radiotherapy."
The Oxford Centre will work towards developing less invasive treatments and support multidisciplinary research by funding for computer sciences to provide better access to knowledge bases and biological data.
The Manchester Centre will profile patients’ blood samples for DNA and cancer cells that are released from the tumour. The information will then be used to personalise drugs, as well as surgery and radiotherapy.
The Cambridge Centre will work towards improving the detection and treatment of cancer by developing programmes in early detection, and integrative cancer medicine.
Cancer Research UK opened the Manchester Cancer Research Centre in collaboration with the University of Manchester and the Christie NHS Foundation Trust earlier this month.
The building is expected to bring together scientists and researchers worldwide to work together on cancer research.
Image: The Major Centres will support national and international collaborations on cancer research. Photo: courtesy of Cancer Research UK.